Morgan Stanley’s Alpha Tau Medical DRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$533K Buy
42,354
+17,883
+73% +$162K ﹤0.01% 5523
2026
Q1
$173K Buy
24,471
+5,358
+28% +$37.8K ﹤0.01% 5933
2025
Q4
$94.6K Sell
19,113
-30,895
-62% -$130K ﹤0.01% 6227
2025
Q3
$226K Buy
50,008
+11,458
+30% +$39K ﹤0.01% 5850
2025
Q2
$120K Sell
38,550
-4,791
-11% -$13.5K ﹤0.01% 6067
2025
Q1
$109K Buy
43,341
+390
+0.9% +$1.22K ﹤0.01% 5967
2024
Q4
$133K Sell
42,951
-390
-0.9% -$998 ﹤0.01% 5940
2024
Q3
$103K Hold
43,341
﹤0.01% 5998
2024
Q2
$110K Sell
43,341
-265,241
-86% -$675K ﹤0.01% 5929
2024
Q1
$910K Buy
308,582
+3,400
+1% +$10.4K ﹤0.01% 5006
2023
Q4
$919K Buy
305,182
+264,879
+657% +$853K ﹤0.01% 4969
2023
Q3
$153K Hold
40,303
﹤0.01% 5700
2023
Q2
$176K Buy
40,303
+21,700
+117% +$77.8K ﹤0.01% 5700
2023
Q1
$53.4K Hold
18,603
﹤0.01% 6263
2022
Q4
$59.2K Buy
18,603
+7,020
+61% +$29K ﹤0.01% 6218
2022
Q3
$67K Sell
11,583
-6,922
-37% -$61.1K ﹤0.01% 6265
2022
Q2
$167K Buy
18,505
+11,655
+170% +$104K ﹤0.01% 5983
2022
Q1
$81K Buy
+6,850
New +$80.5K ﹤0.01% 6452

Other funds holding DRTS

Morgan Stanley's DRTS Position: Q2 2026 in Review

Morgan Stanley increased its Alpha Tau Medical (DRTS) stake by 73% in Q2 2026, buying an estimated $162K and bringing the position to 42,354 shares worth $533K. The position accounts for ﹤0.01% of the portfolio, ranked #5523.

Morgan Stanley first reported a position in DRTS in Q1 2022 and has held it in 18 quarters since. The position peaked at $919K in Q4 2023. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

  • Morgan Stanley held 42,354 shares of Alpha Tau Medical worth $533K as of Q2 2026.
  • Morgan Stanley bought 17,883 Alpha Tau Medical shares in Q2 2026, an estimated $162K.
  • Alpha Tau Medical made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5523 holding.
  • Morgan Stanley first reported a position in Alpha Tau Medical in Q1 2022 and has held it in 18 quarters since.
  • Morgan Stanley's Alpha Tau Medical position peaked at $919K in Q4 2023.
  • 74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.